LT - HPV16 ir HPV18 kaip vakcinos panaudojimas prieš vieną arba daugiau onkogeninių HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 tipų
EN - Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
Legal status
Patent expired
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 39/12 |
(2006.01) |
European patent
| (11) |
Number of the document |
1572233 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
03789346.8 |
|
Date of filing the European patent application |
2003-12-18 |
| (97) |
Date of publication of the European application |
2005-09-14 |
| (45) |
Date of publication and mention of the grant of the patent |
2011-03-30
|
| (46) |
Date of publication of the claims translation |
2011-06-27
|
PCT application
| (86) |
Number |
PCT/EP2003/014562 |
|
Date |
2003-12-18 |
PCT application publication
| (87) |
Number |
WO 2004/056389 |
|
Date |
2004-07-08 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
435035 P |
2002-12-20
|
US |
|
496653 P |
2003-08-20
|
US |
Inventors
| (72) |
DUBIN, Gary, US
INNIS, Bruce, US
SLAOUI, Moncef, M., US
WETTENDORFF, M.A.C., BE
|
Grantee
| (73) |
GlaxoSmithKline Biologicals s.a.,
rue de l`Institut 89, 1330 Rixensart,
BE
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
HPV16 ir HPV18 kaip vakcinos panaudojimas prieš vieną arba daugiau onkogeninių HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 tipų |
| |
Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2022-11-22 |
|
347.00
EUR
|
